Bausch & Lomb Corp Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Bausch & Lomb Corp (BLCO) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$1.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-29
- Bausch & Lomb Corp effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Bausch & Lomb Corp effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-03-31 was $9.00M.
- Bausch & Lomb Corp effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was -$5.00M, a 171.43% decline year-over-year.
- Bausch & Lomb Corp effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was $7.00M.
- Bausch & Lomb Corp effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was $28.00M.
- Bausch & Lomb Corp effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was -$16.00M, a 900.00% decline from fiscal 2023.
- Bausch & Lomb Corp effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was $2.00M.
- Bausch & Lomb Corp effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was -$8.00M.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.00M 10-Q · filed 2026-07-29 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-04-29 | |||
| 2025-12-31 | $28.00M 10-K · filed 2026-02-18 | |||
| 2025-09-30 | $27.00M 10-Q · filed 2025-10-29 | |||
| 2025-06-30 | $31.00M 10-Q · filed 2026-07-29 | |||
| 2025-03-31 | $9.00M 10-Q · filed 2026-04-29 | |||
| 2024-12-31 | -$16.00M 10-K · filed 2026-02-18 | |||
| 2024-09-30 | $1.00M 10-Q · filed 2025-10-29 | |||
| 2024-06-30 | -$9.00M 10-Q · filed 2025-07-30 | |||
| 2024-03-31 | -$5.00M 10-Q · filed 2025-04-30 | |||
| 2023-12-31 | $2.00M 10-K · filed 2026-02-18 | |||
| 2023-09-30 | -$6.00M 10-Q · filed 2024-10-30 | |||
| 2023-06-30 | $3.00M 10-Q · filed 2024-08-01 | |||
| 2023-03-31 | $7.00M 10-Q · filed 2024-05-01 | |||
| 2022-12-31 | -$8.00M 10-K · filed 2025-02-19 | |||
| 2022-09-30 | -$29.00M 10-Q · filed 2023-11-01 | |||
| 2022-06-30 | -$11.00M 10-Q · filed 2023-08-02 | |||
| 2022-03-31 | -$1.00M 10-Q · filed 2023-05-03 | |||
| 2021-12-31 | -$8.00M 10-K · filed 2024-02-21 | |||
| 2021-09-30 | -$8.00M 10-Q · filed 2022-11-02 | |||
| 2021-06-30 | -$5.00M 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | -$7.00M 10-Q · filed 2022-06-08 | |||
| 2020-12-31 | $12.00M 10-K · filed 2023-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B |